ClinicalTrials.gov
ClinicalTrials.gov Menu

Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00686829
Recruitment Status : Completed
First Posted : May 30, 2008
Last Update Posted : February 23, 2015
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.